Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on…
December 29, 2023
Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on…
December 28, 2023
The US neurostimulation device market is characterized by ongoing product innovation; iterative device improvements are regularly launching in established segments—such as the SCS and DBS device…
December 26, 2022
December 23, 2022
December 24, 2021
December 21, 2021
September 22, 2020
September 11, 2020
June 24, 2019